Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1084 | 2761 | 30.0 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
107 | 24427 | PROSTATE CANCER//RADICAL PROSTATECTOMY//PROSTATECTOMY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PROSTATE SPECIFIC ANTIGEN | Author keyword | 245 | 25% | 31% | 854 |
2 | FREE PSA | Author keyword | 178 | 86% | 3% | 89 |
3 | FREE PROSTATE SPECIFIC ANTIGEN | Author keyword | 102 | 95% | 1% | 35 |
4 | COMPLEXED PSA | Author keyword | 57 | 95% | 1% | 19 |
5 | PROPSA | Author keyword | 51 | 91% | 1% | 21 |
6 | PSA | Author keyword | 46 | 16% | 10% | 268 |
7 | PERCENT FREE PSA | Author keyword | 41 | 90% | 1% | 18 |
8 | COMPLEXED PROSTATE SPECIFIC ANTIGEN | Author keyword | 33 | 100% | 0% | 13 |
9 | TOTAL PROSTATE SPECIFIC ANTIGEN | Author keyword | 27 | 92% | 0% | 11 |
10 | ANTIGENS NEOPLASM | Author keyword | 19 | 39% | 1% | 38 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROSTATE SPECIFIC ANTIGEN | 245 | 25% | 31% | 854 | Search PROSTATE+SPECIFIC+ANTIGEN | Search PROSTATE+SPECIFIC+ANTIGEN |
2 | FREE PSA | 178 | 86% | 3% | 89 | Search FREE+PSA | Search FREE+PSA |
3 | FREE PROSTATE SPECIFIC ANTIGEN | 102 | 95% | 1% | 35 | Search FREE+PROSTATE+SPECIFIC+ANTIGEN | Search FREE+PROSTATE+SPECIFIC+ANTIGEN |
4 | COMPLEXED PSA | 57 | 95% | 1% | 19 | Search COMPLEXED+PSA | Search COMPLEXED+PSA |
5 | PROPSA | 51 | 91% | 1% | 21 | Search PROPSA | Search PROPSA |
6 | PSA | 46 | 16% | 10% | 268 | Search PSA | Search PSA |
7 | PERCENT FREE PSA | 41 | 90% | 1% | 18 | Search PERCENT+FREE+PSA | Search PERCENT+FREE+PSA |
8 | COMPLEXED PROSTATE SPECIFIC ANTIGEN | 33 | 100% | 0% | 13 | Search COMPLEXED+PROSTATE+SPECIFIC+ANTIGEN | Search COMPLEXED+PROSTATE+SPECIFIC+ANTIGEN |
9 | TOTAL PROSTATE SPECIFIC ANTIGEN | 27 | 92% | 0% | 11 | Search TOTAL+PROSTATE+SPECIFIC+ANTIGEN | Search TOTAL+PROSTATE+SPECIFIC+ANTIGEN |
10 | ANTIGENS NEOPLASM | 19 | 39% | 1% | 38 | Search ANTIGENS++NEOPLASM | Search ANTIGENS++NEOPLASM |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALPHA 1 ANTICHYMOTRYPSIN | 358 | 56% | 16% | 440 |
2 | DIGITAL RECTAL EXAMINATION | 178 | 37% | 14% | 391 |
3 | TOTAL PSA | 108 | 76% | 3% | 76 |
4 | PSA | 94 | 26% | 11% | 307 |
5 | FREE PSA | 87 | 73% | 2% | 67 |
6 | GAMMA SEMINOPROTEIN | 81 | 83% | 2% | 45 |
7 | HUMAN GLANDULAR KALLIKREIN | 78 | 46% | 5% | 125 |
8 | HK2 | 77 | 73% | 2% | 59 |
9 | PERCENT FREE PSA | 65 | 84% | 1% | 36 |
10 | NG ML | 51 | 39% | 4% | 103 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Prostate specific antigen: A decade of discovery - What we have learned and where we are going | 1999 | 334 | 112 | 70% |
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring | 2008 | 246 | 124 | 41% |
Biology of prostate-specific antigen | 2003 | 263 | 112 | 56% |
Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: Systematic review and meta-analysis | 2005 | 115 | 92 | 78% |
Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis | 2013 | 28 | 28 | 75% |
Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): Two closely related, but distinct, kallikreins in the prostate | 1998 | 200 | 354 | 71% |
Free prostate-specific antigen in serum is becoming more complex | 2002 | 89 | 41 | 90% |
Prostate-specific antigen in clinical practice | 2007 | 64 | 49 | 57% |
Prostate-specific antigen and other serum and urine markers in prostate cancer | 2014 | 10 | 189 | 48% |
Biomarkers for Prostate Cancer | 2009 | 80 | 87 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BUSINESS GRP DIAGNOST | 8 | 50% | 0.4% | 11 |
2 | NW PROSTATE | 6 | 53% | 0.3% | 8 |
3 | HORMONAL BIOREGULAT | 5 | 60% | 0.2% | 6 |
4 | BIOCHEM MOL GENET CDB | 4 | 56% | 0.2% | 5 |
5 | PROSTAT PATHOL UNIT | 4 | 56% | 0.2% | 5 |
6 | UNIV HOSP UMAS | 4 | 28% | 0.4% | 11 |
7 | NAZL PLICAZ BIOTECNOL ONCOL | 3 | 100% | 0.1% | 3 |
8 | BIOREGULAT HORMONALE | 2 | 67% | 0.1% | 2 |
9 | EMI U0010 | 2 | 67% | 0.1% | 2 |
10 | FORENS BIOL UNIT | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000198597 | ACTIVE SURVEILLANCE//WATCHFUL WAITING//PROSTATE SPECIFIC ANTIGEN |
2 | 0.0000168283 | PROSTATE US STUDIES//INCIDENTAL PROSTATE CANCER//TRANSRECTAL ULTRASOUND |
3 | 0.0000156872 | PROSTATIC ACID PHOSPHATASE//SECT UROL SURG//PROSTATIC PHOSPHATASE |
4 | 0.0000122648 | NETHERTON SYNDROME//KALLIKREINS//KALLIKREIN RELATED PEPTIDASES |
5 | 0.0000096786 | JAMAICA CANC REGISTRY//PROSTATE CANC PROJECT//AFRICAN AMERICAN MEN |
6 | 0.0000075475 | RADICAL PROSTATECTOMY//PROSTATECTOMY//SALVAGE RADIOTHERAPY |
7 | 0.0000071518 | FOCAL THERAPY//TARGETED BIOPSY//PROSTATE BIOPSY |
8 | 0.0000068635 | PCA3//TMPRSS2 ERG//PROSTATE CANCER ANTIGEN 3 |
9 | 0.0000059980 | HUHS1015//CHRONIC PROSTATIC INFLAMMATION//NAFTOPIDIL |
10 | 0.0000050873 | EPPIN//PROTEIN SV IV//SEMENOGELIN |